Epidemiology of Chikungunya in the Americas

Chikungunya virus (CHIKV) emerged in the Americas in late 2013 to cause substantial acute and chronic morbidity. About 1.1 million cases of chikungunya were reported within a year, including severe cases and deaths. The burden of chikungunya is unclear owing to inadequate disease surveillance and underdiagnosis. Virus evolution, globalization, and climate change may further CHIKV spread. No approved vaccine or antiviral therapeutics exist. Early detection and appropriate management could reduce the burden of severe atypical and chronic arthritic disease. Improved surveillance and risk assessment are needed to mitigate the impact of chikungunya.

Source: The Journal of Infectious Diseases - December 4, 2016 Category: Infectious Diseases Authors: Yactayo, S., Staples, J. E., Millot, V., Cibrelus, L., Ramon-Pardo, P. Tags: CHIKUNGUNYA Source Type: research